Study finds multidrug-resistant gram-negative bacteria high in long-term care
Residents at long-term care facilities are one of the main reservoirs of antimicrobial-resistant bacteria. Epidemiological studies have focused primarily on two common antimicrobial-resistant organisms—methicillin-resistant Staphylococcus aureas (MRSA) and vancomycin-resistant enterococci (VRE).
“Recently, it has become apparent that multidrug resistance among gram-negative bacteria is becoming an even greater problem in these facilities, with nearly half of long-term care facility residents harboring multidrug-resistant gram-negative bacteria,” write the researchers, led by IFAR's Erin'O'Fallon, M.D., M.P.H., in the January issue of the Journal of Gerontology: Medical Sciences.
MDRGN infection can lead to toxins in the bloodstream that cause inflammation and destroy healthy tissue. Left untreated, these infections can be fatal.
More than 80 percent of the MDRGN cases in the study were resistant to commonly prescribed antimicrobial medications, including ciprofloxacin, trimethoprim-sulfamethoxazole, and amipicillin/sulbactam. By definition all of the identified MDRGN bacteria were resistant to at least three different classes of antimicrobial drugs, with one-third of them resistant to four.
These findings, says Dr. O'Fallon, a staff geriatrician at Hebrew Rehabilitation Center and a research fellow in medicine at Harvard Medical School, raise concerns about the therapeutic options available to physicians in treating long-term care residents with MDRGN. Hospitals and long-term care facilities have only recently begun to include MDRGN in their surveillance of antimicrobial-resistant bacteria and have extended requirements for contact precautions to MDRGN.
Using more than 1,660 clinical cultures (urine, blood and wound specimens) obtained from residents at a large, urban long-term care facility, the researchers found 180 cases of MDRGN compared to 104 cases of MRSA and 11 cases of VRE. Of further concern, they say, was the steady rise in MDRGN over the two-year study period, which increased from 7 percent the first year to 13 percent in the last year.
Dr. O'Fallon says that infections caused by MDRGN are associated with higher mortality rates, longer hospital stays, and increased costs compared with infections caused by gram-negative bacterial infections that can be treated effectively with antibiotics. Risk factors for MDRGN infection in the long-term care population include pressure ulcers, poor functional status, advanced dementia, and antimicrobial exposure.
Scientists at HSL's Institute for Aging Research conduct rigorous medical and social studies, leading the way in developing strategies for maximizing individuals' strength, vigor and physical well-being, as well as their cognitive and functional independence, in late life.
All news from this category: Life Sciences
Articles and reports from the Life Sciences area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Optically Active Defects Improve Carbon Nanotubes
Heidelberg scientists achieve defect control with a new reaction pathway. The properties of carbon-based nanomaterials can be altered and engineered through the deliberate introduction of certain structural “imperfections” or defects….
Visualizing the motion of vortices in superfluid turbulence
Nobel laureate in physics Richard Feynman once described turbulence as “the most important unsolved problem of classical physics.” Understanding turbulence in classical fluids like water and air is difficult partly…
Toward a reliable oral treatment for sickle cell disease
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that…